Lack of pretreatment cost-effectiveness and side effects of omalizumab versus prednisone/montelukast on tolerability of immunotherapy.
作者信息
Rosenberg J Loren
出版信息
J Allergy Clin Immunol. 2011 Feb;127(2):548; author reply 548-9. doi: 10.1016/j.jaci.2010.10.055.
PMID:21281877
Abstract
摘要
相似文献
1
Lack of pretreatment cost-effectiveness and side effects of omalizumab versus prednisone/montelukast on tolerability of immunotherapy.与泼尼松/孟鲁司特相比，奥马珠单抗在免疫治疗耐受性方面缺乏预处理成本效益及副作用。
J Allergy Clin Immunol. 2011 Feb;127(2):548; author reply 548-9. doi: 10.1016/j.jaci.2010.10.055.
2
Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.奥马珠单抗预处理对变应性哮喘特异性免疫治疗耐受性的影响。
J Allergy Clin Immunol. 2010 Feb;125(2):383-9. doi: 10.1016/j.jaci.2009.11.022.
3
Montelukast might improve compliance with subcutaneous immunotherapy treatments in patients with allergic asthma.
J Allergy Clin Immunol. 2011 Jan;127(1):286; author reply 286-7. doi: 10.1016/j.jaci.2010.07.033. Epub 2010 Sep 20.
4
Montelukast treatment may alter the early efficacy of immunotherapy in children with asthma.孟鲁司特治疗可能改变哮喘儿童免疫治疗的早期疗效。
J Allergy Clin Immunol. 2010 Jun;125(6):1220-7. doi: 10.1016/j.jaci.2010.02.034.
5
Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves.采用净效益方法和成本效益可接受性曲线确定丙酸氟替卡松-沙美特罗与孟鲁司特治疗持续性哮喘的经济可行性。
Ann Allergy Asthma Immunol. 2005 Aug;95(2):181-9. doi: 10.1016/S1081-1206(10)61209-4.
6
Revisiting the cost-effectiveness of omalizumab.重新审视奥马珠单抗的成本效益。
Allergy. 2007 Dec;62(12):1469. doi: 10.1111/j.1398-9995.2007.01391.x.
7
Omalizumab for severe allergic asthma: dollars and sense.
J Allergy Clin Immunol. 2007 Nov;120(5):1015-7. doi: 10.1016/j.jaci.2007.09.027.
8
Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.在开始使用哮喘控制疗法的有既往过敏处方的哮喘儿童中，哮喘急救药物和过敏药物的使用情况。
Ann Allergy Asthma Immunol. 2005 Aug;95(2):129-36. doi: 10.1016/S1081-1206(10)61201-X.
9
Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.丙酸氟替卡松与沙美特罗单一装置、丙酸氟替卡松以及孟鲁司特对哮喘总体控制、急性加重及费用的影响。
Ann Allergy Asthma Immunol. 2004 Dec;93(6):581-8. doi: 10.1016/S1081-1206(10)61267-7.
10
Omalizumab: overview of pharmacology and efficacy in asthma.奥马珠单抗：哮喘药理学及疗效概述
Expert Opin Biol Ther. 2009 Jul;9(7):933-43. doi: 10.1517/14712590903036060.
Zotero 插件